These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9860006)
1. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Jabs DA; Bolton SG; Dunn JP; Palestine AG Am J Ophthalmol; 1998 Dec; 126(6):817-22. PubMed ID: 9860006 [TBL] [Abstract][Full Text] [Related]
2. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001 [TBL] [Abstract][Full Text] [Related]
3. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810 [TBL] [Abstract][Full Text] [Related]
4. Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy. Curi AL; Muralha A; Muralha L; Pavesio C Br J Ophthalmol; 2001 Apr; 85(4):471-3. PubMed ID: 11264139 [TBL] [Abstract][Full Text] [Related]
5. AIDS therapy. New hope against blindness. Cohen J Science; 1995 Apr; 268(5209):368-9. PubMed ID: 7716538 [No Abstract] [Full Text] [Related]
6. Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS. Jabs DA Br J Ophthalmol; 2001 Apr; 85(4):381-2. PubMed ID: 11264121 [No Abstract] [Full Text] [Related]
7. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259 [TBL] [Abstract][Full Text] [Related]
8. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644 [TBL] [Abstract][Full Text] [Related]
10. New therapies for cytomegalovirus retinitis. Schwartz DM Int Ophthalmol Clin; 1996; 36(2):1-9. PubMed ID: 8950629 [No Abstract] [Full Text] [Related]
11. Recurrent iritis after intravenous administration of cidofovir. Palau LA; Tufty GT; Pankey GA Clin Infect Dis; 1997 Aug; 25(2):337-8. PubMed ID: 9332544 [No Abstract] [Full Text] [Related]
12. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA; Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304 [TBL] [Abstract][Full Text] [Related]
13. New issues in the management of cytomegalovirus retinitis in AIDS patients. Pau AK Am J Health Syst Pharm; 1998 Feb; 55(4):392-5. PubMed ID: 9504201 [No Abstract] [Full Text] [Related]
14. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. Margolis TP Surv Ophthalmol; 2000; 44(5):455. PubMed ID: 10809654 [No Abstract] [Full Text] [Related]
15. [Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)]. Best J; Althaus C; Kersten A; Theisen A; Gantke B Ophthalmologe; 2000 Aug; 97(8):574-6. PubMed ID: 10994337 [TBL] [Abstract][Full Text] [Related]
16. Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group. Berenguer J; Mallolas J Clin Infect Dis; 2000 Jan; 30(1):182-4. PubMed ID: 10619750 [TBL] [Abstract][Full Text] [Related]
18. Management of CMV infections in HIV-infected patients. Hoy J Adv Exp Med Biol; 1999; 458():77-87. PubMed ID: 10549381 [No Abstract] [Full Text] [Related]
19. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839 [TBL] [Abstract][Full Text] [Related]
20. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Vrabec TR; Baldassano VF; Whitcup SM Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]